MRC NW-DMS DLA programme: Mechanistic investigation into covalent kinase inhibitor-induced liver injury following checkpoint inhibitor treatment
University of Liverpool
Faculty of Health and Life Sciences
Despite years of intensive research, cancer has poor patient outcomes largely due to late-stage diagnosis, limited treatment options, and lack of biomarkers for early detection. Read more
Supervisors: Prof D Naisbitt, Dr X Meng, Dr S Bates
27 November 2026
PhD Research Project
Competition Funded PhD Project (Students Worldwide)